An in vitro flow model was used to examine the influence of peak concentration (Cmax), the area under the antibiotic concentration-time curve (AUC), the magnitude of AUC above the MIC, and the aggregate time the antibiotic concentration exceeds the MIC (TMIC) on the bactericidal effect of ampicillin against Escherichia coli ATCC 12407. Bacteria in the log phase were exposed to therapeutically realistic drug regimens. Ampicillin concentration and bacterial density (CFU per milliliter) were measured over time. Four parameters reflecting bactericidal activity were quantitated: difference between initial and minimum and initial and final bacterial densities, area under the bacterial density-time curve, and a fourth parameter, Z, which is a function of these three. Multiple regression analysis confirmed AUC as the major factor in predicting bactericidal activity. An AUC of >70 ug-h/ml correlated with the lack of emergence of resistance.
Since penicillin G was introduced in 1941, the dependence of therapeutic -effect on antibiotic dose and administration schedule has been the focus of considerable investigative effort. The importance of this issue was demonstrated by Eagle et al. (5) and Miller et al. (20) who observed that the median effective total amount of penicillin G administered varied 100-fold depending on the size and frequency of individual doses. It is clear from such work that the time course of antibiotic concentration in serum is an important determinant of efficacy, but it has been difficult to identify a descriptor(s) of the P-lactam concentration-time curve with which antibacterial activity will be correlated. Among those considered have been the area under the antibiotic concentration-time curve (AUC), the magnitude of the AUC above the MIC (AUC > MIC), the total time that antibiotic concentration exceeds the MIC (TMIC), and the maximum antibiotic concentration attained during a dosing interval (Cmax) (3, 6-9, 11, 12) . These descriptors of dosing regimen are a function of dose and frequency of administration as well as clearance and volume of distribution.
Ampicillin is most commonly administered as a series of intermittent bolus doses. The regimen is designed to maintain antibiotic concentrations in serum above the MIC for some portion of the dosing interval, but it is not clear that time above the MIC should be considered a more important feature of the dosage regimen than other characteristics, e.g., Cmax or AUC (7, 8, 14, 19) . Further, it is not clear whether there is an independent effect of half-life (which is a function of clearance and volume of distribution) or dosing interval or whether these factors are important only insofar as they affect AUC, AUC > MIC, Cmax, and TMIC.
We examined the dependence of the bactericidal activity of ampicillin on AUC, AUC > MIC, TMIC, and Cmax in in vitro studies with Escherichia coli ATCC 12407 in which ampicillin half-life and dosing interval were varied. * Corresponding author.
MATERIALS AND METHODS
Kinetic model. A modified Grasso in vitro kinetic dilution model was used to expose E. coli to various ampicillin concentration-time profiles (Fig. 1) (11) . The flow of drugand bacteria-free medium into the bacterial flask in this model allows a range of drug half-lives to be simulated. However, flow also results in the dilution of bacteria, which, if not corrected for, could not be distinguished from the bactericidal activity of the antibiotic. The correction for flow is made with the following equation:
where N, is the measured bacterial density, Nmax is the maximum attainable bacterial density had there been no flow, ke is the elimination rate constant, and N,' is the bacterial density which would have been observed had there been no flow (27) . In each study, bacteria were exposed to the drug for 12 h. Doses of ampicillin were repeated as required by the dosing interval to maintain a 12-h total exposure. Dosing interval was varied to yield a range of AUC, Cmax, and TMIC.
Bacteria. E. coli ATCC 12407 was used in these experiments. The general experimental procedure was as follows. An overnight culture of E. coli in Mueller-Hinton broth (Difco Laboratories, Detroit, Mich.) was diluted to 102 CFU/ml and allowed to grow to 10i CFU/ml in the same medium. A 1-ml sample of the 107-CFU/ml culture was added to the test flask, resulting in a density of 105 CFU/ml.
When the bacteria reached a density of 107 CFU/ml (in the logarithmic growth phase), the dose of ampicillin required to obtain the desired initial drug concentration was added to the test flask and the peristaltic pump was started. Samples for determination of bacterial density were obtained at 0. 
2T' 1max TIME densities and represents the initial decrease in viable cell density associated with antibiotic addition. ANtot is the difference between the bacterial density at the beginning and end of the 12-h study and represents the regrowth phase (in which the emergence of resistance becomes apparent) over two or more dosing intervals. BAUC is the area under the bacterial concentration-time curve divided by the initial inoculum size. BAUC is a time-integrated parameter and is affected by cell death, stationary, and regrowth phases. The parameter L is introduced in an attempt to obtain a single parameter which is a function of the three fundamental parameters. l is calculated by assigning a rank of 10 to the lowest value of each respective fundamental parameter (ANmax, ANtot) and BAUC) observed in all studies conducted with a given strain of bacteria. A score of 1 is assigned to the maximum value of each parameter. Scores are assigned to other values of a given parameter by linear interpolation between these extremes. l is the sum of the ranks thus assigned to the values of the respective parameters. A value of E is calculated for each exposure condition.
Ampicillin assay. Ampicillin concentration was determined by a standard disk diffusion microbiological method (24 Mueller-Hinton broth. The lower limit of detection was 0.5 ,ug/ml, and the coefficient of variation of the slope of the standard curve was 6.6% over a 2-year period. Determination of pharmacokinetic parameters. The in vitro system is designed such that antibiotic concentration will decline monoexponentially. The actual elimination rate constant, ke and maximum concentration, Cmax, were determined by linear regression. AUC and AUC > MIC were calculated by the trapezoidal rule over the 12-h period of each study (10 Fig. 3 ; parameter values calculated from these raw data are summarized in row 3 of Table 1 . The dosing interval was 6 h and the half-life of ampicillin was approximately 1 h; this allowed drug concentration to exceed the MIC for 6 h of the 12-h study. Ampicillin was effective in killing bacteria (Cmax was nine times the MIC and ANmax was -3.3 log CFU/ml, i.e., 10-3-3 CFU/ml). However, there was a net growth of bacteria over the period of exposure; AN,., was 1.9 log CFU/ml.
Net growth began 2 h after the first dose and 1 h after the second dose. Table 1 shows the reproducibility of these results in a series of four replicate studies. The replicates shown represent data collected over 1 year.
The results obtained from the various exposure conditions are summarized in Table 2 . Data from individual studies were analyzed by multiple linear regression to determine the descriptor(s) of the antibiotic concentration-time profile most strongly associated with bactericidal activity. Log transformations of Cmax and AUC, referred to as log Cmax and log AUC, were used in the analysis because the log transformations improved the correlation between these parameters and bactericidal efficacy. Log transformation did not improve the correlation between measures of efficacy and any other descriptors of dosage regimen (e.g., TMIC).
The results of the regression analysis are shown in Table  3 . A value of 0 for a coefficient means that inclusion of the parameter with which it is associated does not improve the overall correlation. The absolute value of the regression coefficient is a reflection of the relative importance of a parameter as a determinant of the bactericidal activity of a regimen. The relationship between the various bactericidal parameters and log AUC for E. coli is shown in Fig. 4 .
The apparent emergence of resistance was encountered in Grasso model, regrowth of bacteria has been shown under certain conditions by Haag et al. (13) to be a consequence of adherence of bacteria to the wall of the incubation flask, forming a thin film. The film sheds bacteria into the medium, resulting in apparent regrowth. We evaluated the potential role of this artifact in our system by conducting (in duplicate) incubations without drugs and with a medium flow rate such that the drug half-life would have been 15 min. Results (mean values of the duplicate studies) are shown in Fig. 5 . Bacterial density declined log linearly for the first 4 h of the incubation and then became constant at approximately 3.5 log CFU/ml. The results suggest that some bacteria adhere to the model (in that bacterial density should have been reduced to 1 log CFU/ml at this flow) but that adherence per se cannot account for the regrowth observed in our studies with ampicillin. In addition, growth rate constants at ampicillin concentrations below the MIC were dependent on medium flow rate. The growth rate constant at a medium flow rate of 1.2 ml/min was 0.58 ± 0. (range, 0.8 to 1.2 h-1). When the film accounted for the apparent resistance in the studies by Haag et al. (13) , the growth rate constant was independent of medium flow rate.
DISCUSSION
The analysis of data obtained in dynamic in vitro studies of antibiotic effect has been complicated by the lack of quantitative measures with which to characterize bactericidal activity. We defined four parameters with which this objective can be accomplished. ANmax, AN,,, and BAUC (defined in Materials and Methods) reflect different facets of the bactericidal activity of a dosing regimen. The term X was introduced to provide a method to sum all these measures in a single term and to serve as an overall index of bactericidal activity. However, a high value of E may not translate into the most effective regimen in vivo, as the characteristics of the bactericidal activity of a regimen reflected in ANmax, ANtot, and BAUC are likely not to be of equal importance when other factors such as host defense contribute to the removal of bacteria.
In our studies with ampicillin, AUC was determined to be the most consistent index of bactericidal activity (Table 3 , Fig. 3 ) in agreement with the in vitro results of others (7, 9, 16) . Studies in mice have also shown a correlation between AUC and bactericidal activity (3). However, TMIC has also been suggested to be strongly associated with bactericidal activity in vitro and in vivo (5, 6, 19 (11) .
As mentioned above, Haag et al. (13) showed that the emergence of resistance could be an artifact of in vitro systems owing to the adherence of bacteria to the glass walls of incubation flasks. A similar experiment conducted with E. coli ATCC 12407 indicated that the regrowth observed in these experiments was not an artifact of the in vitro system (Fig. 5 ). In addition, resistance was documented by changes in MIC, and the growth rate constants at an ampicillin concentration of <1 p.g/ml (the MIC for the original inoculum) in our studies were a function of medium flow rate (i.e., ampicillin half-life), whereas Haag et al. (13) pointed out that a constant growth rate as a function of medium flow rate is a hallmark of apparent resistance owing to adherence of bacteria to glass. Although the emergence of resistance is a problem encountered more commonly in vitro than in vivo, suboptimum antibiotic therapy has been shown to allow the emergence of resistant strains in animal studies and in certain patients (1, 18, 21) . The emergence of resistance is of particular concern when the host is immunocompromised (9) . In immunocompromised patients, the results of kinetic in vitro studies may be directly applicable. The observation that resistance is least likely to emerge when AUC is high means that resistance will be least likely when relatively large doses are given frequently. A large dose, frequent administration, or a long half-life alone may be insufficient.
Maintenance of antibiotic concentration above the MIC for the initial inoculum also appears to be insufficient to prevent the emergence of resistance of E. coli to ampicillin. Indeed, a constant ampicillin concentration just above the MIC is likely to allow the emergence of resistant E. coli, whether present initially or arising from a mutation during exposure to the antibiotic. The results of this and other studies (4) suggest that the emergence of resistance will be discouraged if a dosage regimen is adopted which is designed to eradicate the least susceptible organism present at the beginning of therapy.
